Cargando…

Monitoring immunomodulation strategies in type 1 diabetes

Type 1 diabetes (T1D) is a T-cell mediated autoimmune disease. Short-term treatment with agents targeting T cells, B cells and inflammatory cytokines to modify the disease course resulted in a short-term pause in disease activity. Lessons learnt from these trials will be discussed in this review. It...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishnamurthy, Balasubramanian, Lacorcia, Matthew, Kay, Thomas W. H., Thomas, Helen E., Mannering, Stuart I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10279879/
https://www.ncbi.nlm.nih.gov/pubmed/37346035
http://dx.doi.org/10.3389/fimmu.2023.1206874